¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • Case Analysis Merck¡¯s Crixivan   (1 ÆäÀÌÁö)
    1

  • Case Analysis Merck¡¯s Crixivan   (2 ÆäÀÌÁö)
    2

  • Case Analysis Merck¡¯s Crixivan   (3 ÆäÀÌÁö)
    3

  • Case Analysis Merck¡¯s Crixivan   (4 ÆäÀÌÁö)
    4

  • Case Analysis Merck¡¯s Crixivan   (5 ÆäÀÌÁö)
    5

  • Case Analysis Merck¡¯s Crixivan   (6 ÆäÀÌÁö)
    6

  • Case Analysis Merck¡¯s Crixivan   (7 ÆäÀÌÁö)
    7

  • Case Analysis Merck¡¯s Crixivan   (8 ÆäÀÌÁö)
    8

  • Case Analysis Merck¡¯s Crixivan   (9 ÆäÀÌÁö)
    9

  • Case Analysis Merck¡¯s Crixivan   (10 ÆäÀÌÁö)
    10

  • Case Analysis Merck¡¯s Crixivan   (11 ÆäÀÌÁö)
    11

  • Case Analysis Merck¡¯s Crixivan   (12 ÆäÀÌÁö)
    12

  • Case Analysis Merck¡¯s Crixivan   (13 ÆäÀÌÁö)
    13

  • Case Analysis Merck¡¯s Crixivan   (14 ÆäÀÌÁö)
    14

  • Case Analysis Merck¡¯s Crixivan   (15 ÆäÀÌÁö)
    15

  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    15 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • Case Analysis Merck¡¯s Crixivan   (1 ÆäÀÌÁö)
    1

  • Case Analysis Merck¡¯s Crixivan   (2 ÆäÀÌÁö)
    2

  • Case Analysis Merck¡¯s Crixivan   (3 ÆäÀÌÁö)
    3

  • Case Analysis Merck¡¯s Crixivan   (4 ÆäÀÌÁö)
    4

  • Case Analysis Merck¡¯s Crixivan   (5 ÆäÀÌÁö)
    5

  • Case Analysis Merck¡¯s Crixivan   (6 ÆäÀÌÁö)
    6

  • Case Analysis Merck¡¯s Crixivan   (7 ÆäÀÌÁö)
    7

  • Case Analysis Merck¡¯s Crixivan   (8 ÆäÀÌÁö)
    8

  • Case Analysis Merck¡¯s Crixivan   (9 ÆäÀÌÁö)
    9

  • Case Analysis Merck¡¯s Crixivan   (10 ÆäÀÌÁö)
    10



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    10 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

Case Analysis Merck¡¯s Crixivan

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  Case Analysis Merck`s Crixivan.pptx   [Size : 1 Mbyte ]
ºÐ·®   18 Page
°¡°Ý  1,500 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

º»¹®/³»¿ë
_SLIDE_1_
Case Analysis
Merck¡¯s Crixivan
ä¨
_SLIDE_2_
#1
About
Merck
#2
Key Issue
#3
Situation
analysis
#4
Contents
#5
Alternatives
Group 10
Case Analysis
conclusion
&
Recommendation
_SLIDE_3_
Chapter#1
about
research-driven pharmaceutical
R
Merck
Merck
products and Services company.

1. Research

2. Manufacturing

3. Product Marketing

4. Service Marketing

Four major product groups
_SLIDE_4_
Chapter#1
about
Merck
Merck
83¡¯ - HIV virus is found
86¡¯ - Started by Merck Research
92¡¯ ¡±indinavir sulfate¡± discovery
96¡¯ Excellent clinical trials
(Crixivan alone caused HIV levels to drop to
undetectable levels in 44% patients after
6 months of treatment)
-¡¦(»ý·«)



📝 Regist Info
I D : rain********
Date : 2015-12-02
FileNo : 15126947

Cart